Bard Stent Grafts Don't Infringe Gore Patents, Jury Finds
By Vince Sullivan ( March 8, 2017, 3:46 PM EST) -- A Delaware federal jury of four men and four women determined Wednesday that an ultrathin stent graft device produced by C.R. Bard Inc. does not infringe a patent held by W.L. Gore & Associates Inc. and that the patent is invalid over prior art....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.